Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B U Mueller

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Pediatrics|February 1, 1994
Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infectionR N Husson, B U Mueller, M Farley, et al.
The Journal of Infectious Diseases|June 1, 1996
Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infectionS Sei, H Akiyoshi, J Bernard, et al.
Pediatrics|November 1, 1994
Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infectionB U Mueller, K M Butler, V L Stocker, et al.
The Journal of Pediatrics|September 1, 1996
Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virusB U Mueller, S Sei, B Anderson, et al.
Bone Marrow Transplantation|October 24, 2017
NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myelomaB Jeker, U Novak, B Mansouri Taleghani, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosingB U Mueller, B D Anderson, M Q Farley, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected childrenB U Mueller, L L Lewis, G J Yuen, et al.
The Journal of Infectious Diseases|March 10, 2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudineS Jankelevich, B U Mueller, C L Mackall, et al.
Pediatrics|July 4, 1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infectionB U Mueller, J Sleasman, R P Nelson, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Pediatrics|February 1, 1994
Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infectionR N Husson, B U Mueller, M Farley, et al.
The Journal of Infectious Diseases|June 1, 1996
Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infectionS Sei, H Akiyoshi, J Bernard, et al.
Pediatrics|November 1, 1994
Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infectionB U Mueller, K M Butler, V L Stocker, et al.
The Journal of Pediatrics|September 1, 1996
Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virusB U Mueller, S Sei, B Anderson, et al.
Bone Marrow Transplantation|October 24, 2017
NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myelomaB Jeker, U Novak, B Mansouri Taleghani, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosingB U Mueller, B D Anderson, M Q Farley, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected childrenB U Mueller, L L Lewis, G J Yuen, et al.
The Journal of Infectious Diseases|March 10, 2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudineS Jankelevich, B U Mueller, C L Mackall, et al.
Pediatrics|July 4, 1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infectionB U Mueller, J Sleasman, R P Nelson, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Pageof 7